You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH):子公司甦力康擬實施增資擴股及轉讓部分老股
格隆匯 03-03 17:23

格隆匯3月3日丨海正藥業(600267.SH)公佈,為更好地實施“聚焦、瘦身、優化”戰略,推動大健康業務的發展,激發企業活力,浙江海正藥業股份有限公司控股子公司浙江海正甦力康生物科技有限公司(下稱“甦力康”)擬通過引進社會資本的方式對其實施增資擴股及部分老股轉讓。本次增資擴股以及老股轉讓擬以投前估值不低於137,220,000元為基準,計劃增資不低於6000萬元人民幣,老股轉讓不低於4765.02萬元人民幣。上述方案實施均按照國資管理規定以公開掛牌形式進行,掛牌起始價格均為每元註冊資本2.7444元。甦力康在本次增資擴股及老股轉讓完成後不再納入公司合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account